Bispecific J&J Drug Wins Speedy FDA Approval for Treating Head & Neck Cancer
Accelerated FDA approval of Johnson & Johnson’s Rybrevant Faspro covers advanced cases of head and neck cancer. The bispecific antibody was initially approved for treating certain lung cancers.
Experian Health Survey: Providers Struggle Amid Increasing Claim Denials
A new Experian Health survey finds that healthcare providers’ efforts to prevent claims denials are falling short, with many reporting an increase in denials over last year and increasingly complex payer requirements.
The Big Challenge for AI in Healthcare Comes After Approval
Typically, software placed on the market will undergo changes and updates after its initial release. In the case of healthcare AI, changes can occur, often unexpectedly, even when the developers have not updated the model.
Why Physician Leadership Is More Important Than Ever
One voice needs to be increasingly present in the rooms where healthcare’s future is being decided: the physician’s.
Myths of Customer Discovery
Customer discovery is a well accepted idea in any innovation process. At the core of it, it means talking to potential customers about an invention. In reality, it is a more evolved process, and often less understood than it first appears.